BioSpace News Archive

The program will provide research fellows at Massachusetts General Hospital, Brigham and Women’s Hospital and McLean Hospital with exposure to the real-world intersection of business and science and an opportunity to experience the unique business challenges in the life sciences sector.

The audio portion of the presentation will be webcast live and archived on the events page of the Company’s Investor Relations website at ir.oled.com.

Cordlife will issue its ordinary shares at an issue price of SGD0.5 per ordinary share in exchange for all of the outstanding ordinary shares of the Company at US$7.50 per ordinary share.

Velan Capital, L.P. issued the following statement responding to certain misleading claims made by Progenics in its recent letter to stockholders

The Mesothelioma Victims Center is one of top branded sources in the United States for a US Navy Veteran with mesothelioma and their number one goal for people like this is the best possible financial compensation results.

Grant increases the availability of safe surgical care for cleft conditions

Georgia School of Orthodontics is proud to announce that its resident classes of 2019 and 2020 have achieved a 100% passage rate for the American Board of Orthodontics’ Written Examination.

Genentech announced that the Phase III BLOCKSTONE study, conducted by Shionogi & Co., Ltd., met its primary endpoint showing that people exposed to a household member with influenza and treated preventatively with XOFLUZA™ were significantly less likely to develop the disease compared to those treated with placebo.

- Verseon presented their oral drug candidates for diabetic macular edema (DME) at this week’s 2019 BIO International Convention in Philadelphia.

Beactica AB, the Swedish drug discovery company, announced the completion of a new financing round that will enable the company to take its leading pipeline programme in oncology to the next stage.